Original article from: Boston Globe posted on December 29, 2016. by Dante...
The National Emerging Infectious Diseases Laboratories (NEIDL) is part of a national network of secure facilities that study infectious diseases of major public health concern—whether they occur naturally or are introduced deliberately through bioterrorism. Our facility is located in BioSquare, a biomedical research and business park adjacent to Boston University Medical Campus.
The mission of the NEIDL is threefold:
- To perform cutting-edge research on emerging infectious diseases and to develop diagnostic tests, treatments, and vaccines to promote the public’s health through combating infectious diseases.
- To provide training in these areas of research and to support a national response in the event of a biodefense emergency.
- To establish a research facility with the highest attention to community and laboratory safety and security.
State-of-the-art technologies employed in the NEIDL’s design ensure our teams conduct research in safe and secure environments. The comprehensive core research facilities enable basic, translational, and clinical research and the development of products related to emerging infectious diseases. World-renowned experts in emerging and re-emerging infectious diseases lead each of our multidisciplinary research programs.
The NEIDL represents a major step forward in advancing public health and complementing the region’s reputation as the biomedical research hub of the nation.